Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA4098 DNL343Summary: DNL343 is a brain-permeable activator of activated eukaryotic initiation factor 2B (eIF2B). -
BA4101 eIF4E-IN-2Summary: eIF4E-IN-2 is a potent inhibitor of eukaryotic initiation factor 4e. -
BA4102 eIF4A3-IN-18Summary: eIF4A3-IN-18 is an analog. -
BA4103 CMLD012612Summary: CMLD012612 is a class of amidino-rocaglate containing an isohydroxamic acid ester moiety and is a potent inhibitor of eukaryotic initiation factor 4A. -
BA4104 eIF4A3-IN-9Summary: eIF4A3-IN-9 is an analog. -
BA4109 NemorubicinSummary: Nemorubicin is a Doxorubicin derivative with potent antitumor activity. -
BA4111 BMVC2Summary: BMVC2 (o-BMVC) is a disubstituted carbazole derivative of BMVC. -
BA4115 SE-7552Summary: SE-7552, a 2-(difluoromethyl)-1,3,4-oxadiazole (DFMO) derivative, is an orally active, highly selective, non-isohydroxamic acid inhibitor. -
BA4117 TMP195Summary: TMP195 is a selective class IIa histone deacetylase inhibitor. -
BA4118 FT895Summary: FT895 is a potent and selective inhibitor.

